Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
Clinical trial NCT06592170 · RECRUITING
Trial details
- NCT number
- NCT06592170
- Sponsor
- The First Hospital of Jilin University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2025-08-13
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.